Sparrow Clinical Research Institute
Sparrow Clinical Research Institute
Lansing, Michigan, United States17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enlighten Study: The EV-ICD Post Approval Registry | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT06048731 | |
| A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05757869 | |
| Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease | Proteinuric Kidney Disease | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT05312879 | |
| Lead Evaluation for Defibrillation and Reliability Post Approval Study | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachyarrhythmia, Tachycardia, cardiovascular disorder, heart disorder | Enrolling by invitation | Not stated | 2026-08-03 | NCT07005232 | |
| Portico Next Generation Approval Study | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-07-21 | NCT04011722 | |
| CREST-2 Long-term Observational Extension Study | Arterial Occlusive Diseases, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Active, not recruiting | Not stated | 2026-05-28 | NCT05465122 | |
| AMPLATZER PFO Occluder Post Approval Study | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-03-11 | NCT03309332 | |
| Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-02-27 | NCT05581303 | |
| Personalized Therapy Study - Attain Stability Quad Post-Approval Study | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2026-02-04 | NCT04024943 | |
| SyncAV Post-Market Trial | cardiovascular disorder, congestive heart failure, heart disorder, heart failure | Active, not recruiting | Not applicable | 2025-12-18 | NCT04100148 | |
| The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation | Recruiting | Not stated | 2025-10-31 | NCT06324201 | |
| Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder, ventricular tachycardia | Active, not recruiting | Not stated | 2025-10-20 | NCT04496518 | |
| Personalized Therapy Study - HFRS (TriageHF) Post Approval Study | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2025-10-20 | NCT04489225 | |
| EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 4 | 2025-10-06 | NCT05284747 | |
| Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement | Arterial Occlusive Diseases, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, heart valve disorder, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2025-07-24 | NCT04634240 | |
| Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2025-07-20 | NCT02000115 | |
| Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Imprinting Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Prader-Willi syndrome, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 3 | 2025-04-02 | NCT05701774 |